U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Postmarket Drug Safety Information for Patients and Providers
  5. Lovenox (enoxaparin) Information
  1. Postmarket Drug Safety Information for Patients and Providers

Lovenox (enoxaparin) Information

Lovenox (enoxaparin) is a blood-thinning drug used to prevent blood clots in the leg veins in patients who are on bed rest or who are having hip replacement, knee replacement, or abdominal surgery. It is often used along with another anticoagulant drug called warfarin to treat blood clots in the leg. Lovenox is also used in combination with aspirin to reduce complications from heart attacks. 

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program using the contact information at the bottom of this page.

 

Related Information

Regulatory History and Labeling from Drugs@FDA

Back to Top